home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Checking Immune Activation

  May, 31 2007 8:47
your information resource in human molecular genetics
Armed 'killer' cells can re-enter lymph nodes to destroy dendritic cells -- a specialized type of immune cell -- according to a report published online in Nature Immunology. Such killing by antigen-specific T cells reduces further priming of naive immune cells of similar specificity, thereby preventing excessive immune cell activation. The results overturn prevailing notions that lymph nodes provide restrictive environments that prevent entry of activated T cells.

Sallusto and colleagues show 'resting' lymph nodes continue to bar entry to previously activated immune 'killer' cells called effector memory CD8+ T cells. Upon inflammatory signals that occur during infection, however, lymph nodes are activated and transiently express a chemical signal called CXCL9 and recruits memory T cells directly from the bloodstream. These memory cells express a receptor called CXCR3 that recognizes CXCL9.

In addition to checking further immune activation, the CXCL9 entry pathway provides a means to combat pathogens, including viruses such as HIV that replicate in lymph node tissues. The study should also be instructive to those working toward more effective vaccine development and improving efficacy.

Author contact:

Federica Sallusto (Institute for Research in Biomedicine, Bellinzona, Switzerland)
E-mail: fsallusto@irb.unisi.ch

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.